Drug intelligence / Profile preview

choline magnesium trisalicylate

Development stage
Phase 2
Lead developer
Purdue Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

**Choline magnesium trisalicylate** is an oral, non-acetylated salicylate NSAID supplied as a fixed combination of choline salicylate and magnesium salicylate. It produces analgesic, antipyretic, and anti-inflammatory effects through reversible, nonselective suppression of cyclooxygenase-mediated prostaglandin synthesis. It has been marketed for symptomatic treatment of rheumatoid arthritis, osteoarthritis, acute painful shoulder, pain, and fever under brands including Trilisate and Tricosal. It was also investigated with induction chemotherapy in acute myeloid leukemia, where short-term administration reduced leukemic-cell nuclear NF-kappaB activity in a small clinical study.

Brand names
TricosalTrilisate
Other names
choline magnesium salicylatecholine magnesium trisalicylatecholine salicylate + magnesium salicylatecholine salicylate/magnesium salicylateCMT
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on choline magnesium trisalicylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on choline magnesium trisalicylate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call